December 28, 2014 6:14 AM ET

Pharmaceuticals

Company Overview of Novus Fine Chemicals, LLC

Company Overview

Novus Fine Chemicals, LLC manufactures and markets active pharmaceutical ingredients and pharmaceutical products. The company offers d-pseudoephedrine hydrochloride, d-pseudoephedrine sulfate, metformin hydrochloride, anti-hypertension, anti-emetic, and anti-depressant products. It serves pharmaceutical companies; and generic pharmaceutical companies, which produce private labels for OTC products and prescription drugs in the United States, Australia, Canada, Europe, Mexico, Panama, and Puerto Rico. The company was incorporated in 1999 and is based in Carlstadt, New Jersey. As of May 10, 2005, Novus Fine Chemicals, LLC is a subsidiary of Malladi Drugs & Pharmaceuticals Ltd.

426 Orchard Street

Carlstadt, NJ 07072

United States

Founded in 1999

Phone:

201-635-1333

Fax:

201-635-1345

Key Executives for Novus Fine Chemicals, LLC

President
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Soluble Products Co., L.P. United States
Bestech GMP Contracting, Inc. United States
Organics L.L.C. United States
Novartis Finance Corporation United States
American Regent, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Novus Fine Chemicals, LLC, please visit malladi.co.in/novus.htm. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.